Abstract | OBJECTIVE: METHODS: Experimental osteoarthritis was induced in wild-type and PAR-2-deficient mice by sectioning the medial meniscotibial ligament (MMTL), leading to the development of a mild arthropathy. Cartilage degradation and increased subchondral bone formation were assessed as indicators of osteoarthritis pathology. RESULTS: Four weeks following MMTL section, cartilage erosion and increased subchondral bone formation was evident in wild-type mice but was substantially reduced in PAR-2-deficient mice. Crucially, the therapeutic inhibition of PAR-2 in wild-type mice, using either a PAR-2 antagonist or a monoclonal antibody targeting the protease cleavage site of PAR-2, was also equally effective at reducing osteoarthritis progression in vivo. PAR-2 was upregulated in chondrocytes of wild-type but not sham-operated mice. Wild-type mice showed further joint degradation 8 weeks after the induction of osteoarthritis, but PAR-2-deficient mice were still protected. CONCLUSIONS: The substantial protection from pathology afforded by PAR-2 deficiency following the induction of osteoarthritis provides proof of concept that PAR-2 plays a key role in osteoarthritis and suggests this receptor as a potential therapeutic target.
|
Authors | William R Ferrell, Elizabeth B Kelso, John C Lockhart, Robin Plevin, Iain B McInnes |
Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 69
Issue 11
Pg. 2051-4
(Nov 2010)
ISSN: 1468-2060 [Electronic] England |
PMID | 20584806
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Animals
- Arthritis, Experimental
(metabolism, pathology)
- Cartilage, Articular
(metabolism, pathology)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Osteoarthritis
(metabolism, pathology)
- Receptor, PAR-2
(deficiency, physiology)
- Signal Transduction
(physiology)
|